m+Medelevator.RU
← Поиск публикаций
Thrombosis and haemostasis · 2024

Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.

СтатьяConsensus StatementНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Harenberg Job, Gosselin Robert C, Cuker Adam, Becattini Cecilia, Pabinger Ingrid, Poli Sven, Weitz Jeffrey, Ageno Walter, Bauersachs Rupert, Celap Ivana, Choi Philip, Douketis James, Douxfils Jonathan, Elalamy Ismail, Falanga Anna, Fareed Jawed, Favaloro Emmanuel J, Gerotziafas Grigorios, Herkner Harald, Hetjens Svetlana, Heubner Lars, Klamroth Robert, Langer Forian, Lip Gregory Y H, Mac Grory Brian, Margetić Sandra, Merrelaar Anne, Pikta Marika, Renne Thomas, Schulman Sam, Schwameis Michael, Strbian Daniel, Tafur Alfonso, Vassart Julie, Violi Francesco, Walenga Jeanine, Weiss Christel

Аннотация

BACKGROUND: With the widespread use of direct oral anticoagulants (DOACs), there is an urgent need for a rapid assay to exclude clinically relevant plasma levels. Accurate and rapid determination of DOAC levels would guide medical decision-making to (1) determine the potential contribution of the DOAC to spontaneous or trauma-induced hemorrhage; (2) identify appropriate candidates for reversal, or (3) optimize the timing of urgent surgery or intervention.

METHODS AND RESULTS: The DOAC Dipstick test uses a disposable strip to identify factor Xa- or thrombin inhibitors in a urine sample. Based on the results of a systematic literature search followed by an analysis of a simple pooling of five retrieved clinical studies, the test strip has a high sensitivity and an acceptably high negative predictive value when compared with levels measured with liquid chromatography tandem mass spectrometry or calibrated chromogenic assays to reliably exclude plasma DOAC concentrations ≥30 ng/mL.

CONCLUSION: Based on these data, a simple algorithm is proposed to enhance medical decision-making in acute care indications useful primarily in hospitals not having readily available quantitative tests and 24/7. This algorithm not only determines DOAC exposure but also differentiates between factor Xa and thrombin inhibitors to better guide clinical management.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты